DXCM vs FSEA · P/E 63, rev $2.50B vs rev $27.0M
DexCom Inc (DXCM) versus First Seacoast Bancorp (FSEA) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
First Seacoast Bancorp (FSEA) is a banks - regional company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported FSEA revenue for 2025-12-31 was $27.0M. Net income was -$845.0K. Revenue was up 6.1% from 2024-12-31 to 2025-12-31. FSEA currently screens at market cap $53.1M.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. FSEA currently screens at market cap $53.1M.
Not investment advice. Open the DXCM and FSEA stock pages for the full models.
Not investment advice.